cyclosporine has been researched along with Libman-Sacks Disease in 182 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (1.65) | 18.7374 |
| 1990's | 50 (27.47) | 18.2507 |
| 2000's | 61 (33.52) | 29.6817 |
| 2010's | 48 (26.37) | 24.3611 |
| 2020's | 20 (10.99) | 2.80 |
| Authors | Studies |
|---|---|
| Abbas, AS; Abdel-Aziz, TM; Alsaqabi, F; Gouda, W; Islam, MA; Moshrif, A | 1 |
| Chen, Y; Deng, L; Hu, X; Zhang, Y; Zhou, J | 1 |
| Rabelink, TJ; Teng, YKO | 1 |
| Hasegawa, E; Hoshino, J; Ikuma, D; Kinowaki, K; Kono, K; Mizuno, H; Oba, Y; Ohashi, K; Sawa, N; Sawamura, M; Sekine, A; Suwabe, T; Ubara, Y; Yamanouchi, M | 1 |
| Cai, S; Liu, X; Peng, Y | 1 |
| Sander, M | 1 |
| Benvenuti, F; Doria, A; Gatto, M; Iaccarino, L; Larosa, M; Montesso, G; Saccon, F; Zen, M | 1 |
| Bavaharan, B; Kawali, A; Mahendradas, P; Mohan, A; Sanjay, S; Shetty, B | 1 |
| Einwächter, H; Heemann, U; Küchle, C; Lorenz, G; Moog, P; Riedhammer, KM; Schmaderer, C; Schraml, F; Schul, L; Slotta-Huspenina, J; Verbeek, M | 1 |
| van Vollenhoven, R | 1 |
| Furukawa, K; Ichinose, K; Imadome, KI; Kawakami, A; Okamoto, M; Sato, S | 1 |
| Biglia, A; Bozzalla Cassione, E; Cavagna, L; Codullo, V; Montecucco, C; Zanframundo, G | 1 |
| Agarwal, SK; Arora, M; Ganugula, R; Kumar, MNVR; Mohan, C; Zou, D | 1 |
| McHugh, J | 1 |
| Hu, X; Lu, H; Lu, P; Wen, Y | 1 |
| Huizinga, RB; Lisk, L; Solomons, N; van Gelder, T | 1 |
| Bennett, C; Chen, S; Hannon, CW; Lima, HC; McCourt, C | 1 |
| Altincatal, A; Berdofe, A; Centonze, D; de Moor, C; Jung, E; Kim, M; Nagpal, A; Naylor, ML; Popescu, C; Radhakrishnan, M; Rajbhandari, R; Reder, AT; Sandrock, AW; Smirnakis, K | 1 |
| Arriens, C; Caster, DJ; Gibson, K; Ginzler, EM; Huizinga, RB; Kaplan, J; Lisk, L; Navarra, S; Parikh, SV; Randhawa, S; Romero-Diaz, J; Rovin, BH; Solomons, N; Teng, YKO | 1 |
| Bes, C; Erdogan, M; Yalcin Mutlu, M; Yardimci, AH; Yıldırım, F | 1 |
| Chang, YL; Chou, YC; Hsu, CC; Liao, HT; Tsai, CY; Wu, TH; Yang, TH | 1 |
| Choi, YJ; Yoo, WH | 1 |
| Almuwaqqat, Z; Bashtawi, Y; Roberts, JW | 1 |
| Ajlan, RS; Champion, M; Herrera, I; Kam, Y; Whittaker, TJ | 1 |
| Hasegawa, H; Kohsaka, H; Miyasaka, N; Mizoguchi, F | 1 |
| Amano, K; Chino, K; Ito, T; Kato, H; Kondo, T; Kurasawa, T; Nagasawa, H; Nishi, E; Nishimura, K; Ogawa, H; Okuyama, A; Sakai, R; Shibata, A; Takei, H | 1 |
| Ben-Chetrit, E; Tayer-Shifman, OE | 1 |
| Akashi, K; Horiuchi, T; Kiyohara, C; Niiro, H; Oryoji, K; Shimoda, T; Tsukamoto, H; Yanase, T | 1 |
| Jung, SY | 1 |
| Kaneko, H; Kano, T; Mimori, A; Takahashi, Y; Ueda, Y; Yamashita, H | 1 |
| Gladman, DD; Ibañez, D; Touma, Z; Urowitz, MB | 1 |
| D'Amelio, R; Laganà, B; Picchianti-Diamanti, A; Rosado, MM; Scarsella, M | 1 |
| Chang, DM; Chen, WS; Chou, CT; Lai, CC; Tsai, CY; Tsao, YP; Wu, TH | 1 |
| Jeong, DC; Kim, HJ; Kim, SH; Kim, SY; Lee, SJ; Park, JH | 1 |
| Boey, CC; Chong, SY; Khoh, KM; Lee, WS; Lim, CB; Lum, SH; Ng, RT; Pailoor, J; Teo, KM | 1 |
| Hanafusa, T; Kotani, T; Makino, S; Takeuchi, T; Wada, Y; Wakura, D; Wakura, R | 1 |
| Moroni, G; Ponticelli, C | 1 |
| Aleksiejuk, P; Banki, K; Bonilla, E; Francis, L; Landas, SK; Liu, Y; Marchena-Mendez, I; Oaks, Z; Patel, J; Perl, A; Yu, J | 1 |
| Åhlin, A; Hagelberg, S; Olsson, RF; Ringdén, O; Schiller, B; Truedsson, L | 1 |
| Akawatcharangura, P; Osiri, M; Taechakraichana, N | 1 |
| Furie, R; Narain, S | 1 |
| Aytaç, S; Batu, ED; Bilginer, Y; Çetin, M; Gümrük, F; Özen, S; Tuncer, M; Ünal, Ş | 1 |
| Chighizola, CB; Meroni, PL; Ong, VH | 1 |
| Halder, R; Kashyap, R; Malik, R | 1 |
| Elia, M; Huang, J | 1 |
| Jiang, N; Li, MT; Wu, D; Zeng, XF | 1 |
| Doria, A; Moroni, G; Ponticelli, C | 1 |
| Hwang, KP; Kuo, HC; Sheen, JM; Yang, KD; Yeap, ST; Yu, HR | 1 |
| Hong, C; Kalish, RA; Krishnamani, R; Martorell, EA; Patel, AR; Rust, DW; Salomon, RN | 1 |
| Jedlickova, B; Prusa, R; Segethova, J; Tesfaye, H | 1 |
| Akkaya, AD; Göktay, F; Güneş, P; Mansur, AT; Masatlioğlu, SP | 1 |
| Chan, RY; Chin, AC; Huang, HY; Lai, TK; Wong, TC; Wong, WC | 1 |
| Eguchi, K; Ida, H; Imanishi, D; Kawakami, A; Motomura, M; Nakamura, H; Okada, A; Yamasaki, S | 1 |
| Lateef, A; Lau, TC; Tan, KB | 1 |
| Chiu, MC; Lai, WM; Ma, AL | 1 |
| Amano, K; Kameda, H; Ogawa, H; Takeuchi, T | 1 |
| Chen, WS; Hsu, YH; Lee, HT; Shiao, YM; Tsai, CY; Tsai, SF; Wu, TH | 1 |
| Akil, M; Chakravarty, K; Emery, P; Gordon, C; Griffiths, B; Griffiths, ID; Hallengren, C; Isenberg, D; Lorenzi, A; Maddison, P; Miles, S; Nived, O; Plant, M; Ryan, V; Situnayake, D; Sturfelt, G; Tait, T; Teh, LS; Thompson, R | 1 |
| Dönmez, O; Durmaz, O | 1 |
| Aramaki, T; Eguchi, K; Fujikawa, K; Ida, H; Iwamoto, N; Kawakami, A; Kawashiri, SY; Nakamura, H; Origuchi, T; Tamai, M | 1 |
| Fujisawa, T; Seishima, M | 1 |
| Brugos, B; Dul, C; Gubisch, W; Kiss, E; Sipka, S; Szegedi, G; Zeher, M | 1 |
| Chaudhary, P; Gurtoo, A; Jain, M; Kumar Pande, A; Pahuja, S; Sethi, N | 1 |
| Ehara, T; Hashimoto, K; Higuchi, M; Kamijo, Y; Shigematsu, H; Takahashi, K | 1 |
| Asako, K; Kikuchi, H; Ono, Y; Shirasaki, R; Takayama, M; Yamamoto, T | 1 |
| Hinterberger, LR; Müller, CS; Vogt, T | 1 |
| Kiss, CG; Kiss, E; Poór, G | 1 |
| Yamaji, K | 1 |
| Akioka, S; Hamaoka, K; Hosoi, H; Imamura, T; Ito, I; Morimoto, A; Morioka, S; Nishida, M; Nozaki, T; Sugimoto, T | 1 |
| Besbas, N; Bilginer, Y; Cetin, M; Gokce, M; Gumruk, F; Ozaltin, F; Ozen, S | 1 |
| Chiang, BL; Lee, JH; Lin, CI; Lin, YT; Wang, LC; Yang, YH; Yu, HH | 1 |
| Chang, YS; Chen, WS; Chou, CT; Lai, CC; Tsai, CY; Wang, SH | 1 |
| Bennett, TD; Bratton, SL; Brogan, TV; Casper, TC; Fluchel, M; Hayward, KN; Hersh, AL; Hersh, AO; Korgenski, EK; Mundorff, MB; Srivastava, R; Stone, BL | 1 |
| Greene, K; Hansen, JJ; Sigmon, L | 1 |
| Kobayashi, T; Maeshima, E; Mune, M; Yukawa, S | 1 |
| Charalambopoulo, DV; Dimopoulos, AM; Katsiari, CG; Liossis, SN; Mavrikakis, M; Sfikakis, PP | 1 |
| Airò, P; Antonioli, CM; Cattaneo, R; Chirico, G; Faden, D; Motta, M; Tincani, A | 1 |
| Petri, M | 1 |
| La Spina, M; Russo, G | 1 |
| Agarwal, SK; Garg, D; Kubba, S; Makhija, A; Pathania, A; Prakash, A; Prakash, N; Singh, NP | 1 |
| Fjiwara, M; Kinoshita, Y; Ohta, T; Sakano, T; Wakai, M | 1 |
| Gregoor, PS; Weimar, W | 1 |
| Benedetti, E; Bogetti, D; Dong, G; Panaro, F; Rondelli, D; Sammartino, C; Sankary, H; Testa, G | 1 |
| Arcasoy, MO; Chao, NJ | 1 |
| Abbott, KC; Agodoa, LY; Bohen, EM; Koff, J; Lentine, KL; Oglesby, RJ; Schnitzler, MA | 1 |
| Al-Flaiw, A; Al-Ghamdi, G; Ghalib, M; Hala, K; Hejaili, F; Jumani, A; Khader, AA; Qureshi, J; Raza, H; Tahir, S | 1 |
| Kogata, Y; Kumagai, S; Nakazawa, T | 1 |
| Cheng, TT; Wang, SW | 1 |
| De Santis, M; Ferraccioli, GF; Tomietto, P | 1 |
| Von Feldt, JM | 1 |
| Bae, YD; Choi, HJ; Lee, EB; Lee, JC; Shin, KC; Song, YW | 1 |
| Kiss, E; Szegedi, G; Tarr, T; Zeher, M | 1 |
| Bellier, C; Godeau, B; Khellaf, M; Lambotte, O | 1 |
| Azuma, T; Fujii, K; Fujii, Y; Iwata, S; Saito, K; Suzuki, K; Tanaka, Y | 1 |
| Cetkovská, P; Pizinger, K | 1 |
| De Vita, S; Ferraccioli, G; Franzolini, N; Perin, A; Quartuccio, L; Sacco, S | 1 |
| Ito, E; Suzuki, K; Tanaka, H; Tsugawa, K | 1 |
| Lesiak, A; McCauliffe, DP; Salamon, M; Sysa-Jedrzejowska, A; Wozniacka, A | 1 |
| Amoura, Z; Bader-Meunier, B; Delfraissy, JF; Godeau, B; Goujard, C; Harmouche, H; Khellaf, M; Lambotte, O; Manceron, V; Piette, JC | 1 |
| Kotyla, PJ; Kucharz, EJ; Lewicki, M; Sliwińska-Kotyla, B | 1 |
| Hirohata, S; Ishii, M; Katada, Y; Kosaka, H; Mima, T; Muramoto, Y; Ohshima, S; Saeki, Y | 1 |
| Dybała, T; Hrycek, A; Kusmierz, D; Swiatkowska, L | 1 |
| Amano, K; Kameda, H; Nagasawa, H; Ogawa, H; Sekiguchi, N; Takei, H; Takeuchi, T; Tsuzaka, K | 1 |
| Chuang, E; Molitch, ME | 1 |
| Matsuo, S; Nishihara, G; Shimajiri, S; Uchida, E | 1 |
| Enami, T; Goto, D; Hayashi, T; Ito, S; Mamura, M; Matsumoto, I; Sugihara, M; Sumida, T; Suzuki, T; Tsutsumi, A; Yoshimi, A | 1 |
| Biggioggero, M; Borghi, MO; Cimaz, R; Gerosa, M; Meroni, PI; Trespidi, L | 1 |
| Korkmaz, C | 1 |
| Ando, T; Iida, N; Katagiri, A; Kon, T; Takasaki, Y; Yamada, M | 1 |
| Hosoya, M; Isome, M; Kawasaki, Y; Nozawa, R; Suyama, K; Suzuki, H; Suzuki, J; Takano, K | 1 |
| Henmi, K; Hirano, T; Yoshida, M; Yoshikawa, N | 1 |
| De Santis, M; Ferraccioli, G; Gremese, E | 1 |
| Inoh, M; Kurata, N; Maruoka, T; Takahara, J; Tokuda, M | 1 |
| Gotti, E; Remuzzi, G | 1 |
| Favre, H; Huang, YP; Lemoine, R; Miescher, PA | 1 |
| Gergely, P | 2 |
| Nasonov, EL; Nasonova, VA; Shtutman, VZ | 1 |
| Avina-Zubieta, JA; Russell, AS | 1 |
| Favre, H; Lemoine, R; Miescher, PA | 1 |
| Shoenfeld, Y | 1 |
| Follath, F; Fontana, A; Leumann, E; Michel, BA; Miescher, PA; Schreier, M; Schroeder, M; Wenk, M | 1 |
| Arase, K; Asayama, R; Dohmen, K; Ishibashi, H; Kuroiwa, S; Nakamura, H; Ohtsuka, S; Yokogawa, Y | 1 |
| Adams, LM; Sehgal, SN; Warner, LM | 1 |
| De Marzio, P; Giordano, M; Morelli, S; Priori, R; Sgreccia, A; Valesini, G | 1 |
| Inoh, M; Kinashi, M; Kurata, N; Mizoguchi, A; Seto, K; Takahara, J; Tokuda, M | 1 |
| Fox, DA; McCune, WJ | 1 |
| Botella, J; Fernández Fernández, J; Garrancho, JM; Hernández Pérez, J; Sanz Moreno, C | 1 |
| Cummons, T; Nolan, L; Sehgal, SN; Warner, LM | 1 |
| Kalden, JR; Manger, B; Manger, K | 1 |
| Béraud, V; Berbis, P; Kone-Paut, I; Sebahoun, G | 1 |
| Langevitz, P; Livneh, A; Mortinowitz, U; Schulman, S; Seligsohn, U; Varon, D | 1 |
| Yocum, DE | 1 |
| Afeltra, A; Amoroso, A; Bonomo, L; Caccavo, D; Ferri, GM; Laganà, B; Mitterhofer, AP | 1 |
| Little, BB | 1 |
| Bambauer, R; Klinkmann, J; Latza, R; Schiel, R | 2 |
| Scott, DG; Somerville, MF | 1 |
| Bartûnková, J; Dostál, C; Rychlík, I; Stejskalová, A; Tegzova, D; Tesar, V; Vencovský, J; Zabka, J | 1 |
| Hashimoto, H; Hirose, S; Hishikawa, T; Iida, N; Kaneko, H; Ogasawara, H; Sekigawa, I; Sugiyama, M | 1 |
| La Manna, A; Marte, A; Papale, MR; Polito, C; Rocco, CE | 1 |
| Amend, WJ; Criswell, LA; Millward, CL; Olson, JL; Stone, JH | 1 |
| Durántez Martínez, A; García Gasalla, M; López García, E; Vargas Núñez, JA; Villarreal García-Lomas, M; Yebra Bango, M | 1 |
| McCune, WJ; Singer, NG | 1 |
| Bremell, T; Eliasson, B; Eriksson, JW; Fowelin, J; Fredriksson, L; Yu, ZW | 1 |
| Amend, WJ; Criswell, LA; Stone, JH | 1 |
| Banyai, A; Karadi, A; Kilian, K; Miklos, K; Paloczi, K; Patranyi, GG | 1 |
| Dimitrijevic, M; Glisic, B; Mitrovic, D; Pavlica, L; Popovic, M | 1 |
| Hashimoto, H; Hirose, S; Iida, N; Sekigawa, I; Sugiyama, M; Tokano, Y | 1 |
| Kodama, N; Maeshima, E; Mune, M; Yamada, Y; Yukawa, S | 1 |
| Balacco Gabrieli, C; Giorgi, D | 1 |
| Hashimoto, H; Hirose, S; Iida, N; Maeda, N; Matsumoto, M; Sekigawa, I | 1 |
| Fabrizzi, F; Langevitz, P; Levy, Y; Sherer, Y; Shoenfeld, Y | 1 |
| Agliata, S; Airoldi, G; Cavagnino, A; Fortina, F; Ragazzoni, E; Sacco, A; Schweiger, K; Tommasini, G | 1 |
| Awazu, Y; Eto, S; Fujii, K; Kohno, K; Ota, T; Saito, K; Tanaka, Y | 1 |
| Morton, SJ; Powell, RJ | 1 |
| Hallegua, D; Klinenberg, JR; Metzger, AL; Rinaldi, RZ; Wallace, DJ | 1 |
| Ando, S; Hashimoto, H; Hayashi, T; Hirose, S; Iida, N; Matsushita, M; Sekigawa, I | 1 |
| Burgos-Vargas, R; Cazarín-Barrientos, J; Collazo-Jaloma, J; Duarte-Salazar, C; Goycochea-Robles, MV | 1 |
| Bartoli, E; Casatta, L; Dammacco, F; Della Casa Alberighi, O; Ferraccioli, G; Racanelli, V | 1 |
| Kliukvina, NG; Nasonov, EL; Nasonova, VA; Shekshina, SV | 1 |
| Bambauer, R; Schiel, R; Schwarze, U | 1 |
| Mathieu, A; Passiu, G; Pittau, E | 1 |
| Alessandri, C; Conti, F; Medda, E; Priori, R; Spinelli, FR; Valesini, G | 1 |
| Awazu, Y; Fujii, K; Fujii, Y; Nakayamada, S; Ota, T; Saito, K; Tanaka, Y | 1 |
| Chiba, R; Furukawa, M; Mori, Y; Sueishi, M; Sugimoto, T; Sugiyama, T; Tanabe, E | 1 |
| Emery, P; Griffiths, B | 1 |
| Della Casa Alberighi, O; Moroni, G; Ponticelli, C | 1 |
| de la Mata, J; Fernández-Espartero, MC; Rodríguez, M; Satué, JA | 1 |
| Remer, CF; Wallace, DJ; Weisman, MH | 1 |
| Aliavi, AL; Latipova, NS | 1 |
| Calligaro, A; Di Lenardo, L; Doria, A; Gambari, PF; Vaccaro, E; Vario, S | 1 |
| Ben-Bassat, M; Blank, M; Shoenfeld, Y | 1 |
| Giunta, G; Piazza, I | 1 |
| Goronzy, JJ; Jendro, M; Weyand, CM | 1 |
| Corvetta, A; Della Bitta, R; Luchetti, MM; Pomponio, G | 1 |
| Cole, BR; Goss, JA; Hanto, DW; Jendrisak, MD; McCullough, CS; So, SK; Windus, DW | 1 |
| González, T; Hernández-Beriaín, JA; Rodríguez-Lozano, B | 1 |
| Gunn, HC; Hiestand, PC | 1 |
| Gunn, HC; Hanglow, AC; Hiestand, PC | 1 |
| Gunn, HC | 1 |
29 review(s) available for cyclosporine and Libman-Sacks Disease
| Article | Year |
|---|---|
Voclosporin (Lupkynis) for lupus nephritis.
Topics: Administration, Oral; Animals; Calcineurin Inhibitors; Clinical Trials as Topic; Cyclosporine; Humans; Lupus Erythematosus, Systemic; Lupus Nephritis; T-Lymphocytes | 2021 |
Interventions for cutaneous disease in systemic lupus erythematosus.
Topics: Age of Onset; Azathioprine; Bias; Biological Factors; Chloroquine; Cosmetic Techniques; Cyclosporine; Dermatologic Agents; Exanthema; Female; Humans; Hydroxychloroquine; Immunosuppressive Agents; Lupus Erythematosus, Cutaneous; Lupus Erythematosus, Systemic; Male; Medicine, Chinese Traditional; Methotrexate; Placebos; Quality of Life; Randomized Controlled Trials as Topic; Skin Diseases; Symptom Flare Up | 2021 |
Refractory hemophagocytic syndrome in systemic lupus erythematosus successfully treated with intermittent intravenous cyclophosphamide: three case reports and literature review.
Topics: Administration, Intravenous; Adolescent; Adrenal Cortex Hormones; Adult; Antibodies, Monoclonal, Murine-Derived; Antirheumatic Agents; Cyclophosphamide; Cyclosporine; Female; Humans; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Lymphohistiocytosis, Hemophagocytic; Male; Middle Aged; Rituximab; Treatment Outcome; Young Adult | 2014 |
P-glycoprotein and drug resistance in systemic autoimmune diseases.
Topics: Adrenal Cortex Hormones; Arthritis, Psoriatic; Arthritis, Rheumatoid; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cyclosporine; Drug Resistance; Humans; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Tacrolimus | 2014 |
Immunosuppression in pregnant women with systemic lupus erythematosus.
Topics: Contraindications; Cyclosporine; Female; Glucocorticoids; Humans; Hypertension; Immunosuppression Therapy; Isoxazoles; Leflunomide; Lupus Erythematosus, Systemic; Maternal Exposure; Mycophenolic Acid; Pre-Eclampsia; Pregnancy; Pregnancy Complications; Withholding Treatment | 2015 |
Update on clinical trials in systemic lupus erythematosus.
Topics: Abatacept; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; B-Lymphocytes; Clinical Trials as Topic; Cyclosporine; Herpes Zoster; Humans; Immunosuppressive Agents; Interferon Type I; Lupus Erythematosus, Systemic; Lupus Nephritis; Maintenance Chemotherapy; Peptide Fragments; Plasma Cells; Quinolones; Recombinant Fusion Proteins; Remission Induction; T-Lymphocytes; Tacrolimus; Treatment Outcome | 2016 |
The Use of Cyclosporine A in Rheumatology: a 2016 Comprehensive Review.
Topics: Adult; Arthritis, Juvenile; Behcet Syndrome; Child; Cyclosporine; Hepacivirus; Hepatitis C, Chronic; Humans; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Lymphocyte Activation; Rheumatology; Sjogren's Syndrome; Still's Disease, Adult-Onset; T-Lymphocytes; Virus Replication | 2017 |
Cyclosporine (CsA) in lupus nephritis: assessing the evidence.
Topics: Clinical Trials as Topic; Cyclosporine; Humans; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Lupus Nephritis | 2009 |
[Systemic autoimmune disorders and pregnancy].
Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents; Antimalarials; Antiphospholipid Syndrome; Arthritis, Rheumatoid; Autoimmune Diseases; Azathioprine; Cyclophosphamide; Cyclosporine; Drug Administration Schedule; Female; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Isoxazoles; Leflunomide; Lupus Erythematosus, Systemic; Methotrexate; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Remission Induction; Sjogren's Syndrome; Sulfasalazine; Teratogens; Tumor Necrosis Factor-alpha | 2011 |
[Treatment of rheumatic diseases: current status and future prospective. Topics: II. Immunosuppressant/antirheumatic drugs; 7. Cyclosporine].
Topics: Collagen Diseases; Cyclosporine; Humans; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Rheumatic Diseases | 2011 |
Immunosuppressive drug use in pregnancy.
Topics: Adrenal Cortex Hormones; Azathioprine; Breast Feeding; Cyclophosphamide; Cyclosporine; Female; Fetal Diseases; Humans; Hydroxychloroquine; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Maternal-Fetal Exchange; Mycophenolic Acid; Pregnancy; Pregnancy Complications | 2003 |
[Pharmacotherapy of SLE].
Topics: Adrenal Cortex Hormones; Anemia, Hemolytic; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Cyclophosphamide; Cyclosporine; Hypertension, Pulmonary; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Lupus Nephritis; Mycophenolic Acid; Plasma Exchange | 2005 |
Rationale for T cell inhibition by cyclosporin A in major autoimmune diseases.
Topics: Arthritis, Rheumatoid; Autoimmune Diseases; CD28 Antigens; Colitis, Ulcerative; Cyclosporine; Cytokines; Dermatomyositis; Humans; Immune Tolerance; Immunosuppressive Agents; Inflammation; Lupus Erythematosus, Systemic; T-Lymphocytes | 2005 |
[Risk of atherosclerosis development in patients with systemic lupus erythematosus].
Topics: Adrenal Cortex Hormones; Arteriosclerosis; Autoantibodies; Azathioprine; Blood Coagulation Disorders; Cardiovascular Diseases; Causality; Comorbidity; Cyclosporine; Disease Progression; Female; Humans; Lupus Erythematosus, Systemic; Myocardial Infarction; Risk Factors | 2005 |
[Prospects of the use of cyclosporin A in rheumatic diseases].
Topics: Animals; Arthritis, Rheumatoid; Autoimmune Diseases; Behcet Syndrome; Clinical Trials as Topic; Controlled Clinical Trials as Topic; Cyclosporine; Dermatomyositis; Glucocorticoids; Humans; Lupus Erythematosus, Systemic; Mice; Mice, Inbred NZB; Rheumatic Diseases; Sjogren's Syndrome | 1994 |
Immunosuppression of experimental systemic lupus erythematosus and antiphospholipid syndrome.
Topics: Adjuvants, Immunologic; Androgens; Animals; Antibodies, Anti-Idiotypic; Antiphospholipid Syndrome; Aspirin; Bone Marrow Transplantation; Bromocriptine; Cyclosporine; Disease Models, Animal; Estrogens; Ethylenes; Heparin; Hydroxyquinolines; Immunoglobulins, Intravenous; Immunosuppression Therapy; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Lymphocyte Transfusion; Mice; T-Lymphocytes, Regulatory | 1994 |
[Cyclosporin in autoimmune diseases].
Topics: Adult; Arthritis, Rheumatoid; Autoimmune Diseases; Child; Cyclosporine; Humans; Kidney Diseases; Lupus Erythematosus, Systemic; Nephrotic Syndrome | 1994 |
Immunosuppressive drug therapy of systemic lupus erythematosus.
Topics: Azathioprine; Cyclophosphamide; Cyclosporine; Humans; Immunosuppressive Agents; Leukocyte Count; Lupus Erythematosus, Systemic; Lymphocyte Subsets; Lymphocytes; Mechlorethamine; Methotrexate | 1994 |
Cyclosporine, FK-506, rapamycin, and other immunomodulators.
Topics: Arthritis, Psoriatic; Arthritis, Rheumatoid; Clinical Trials as Topic; Cyclosporine; Humans; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Polyenes; Sirolimus; Tacrolimus | 1996 |
Immunosuppressant therapy during gestation.
Topics: Arthritis, Rheumatoid; Azathioprine; Cyclosporine; Female; Humans; Immunosuppressive Agents; Infant, Newborn; Lupus Erythematosus, Systemic; Organ Transplantation; Pregnancy; Pregnancy Complications; Steroids | 1997 |
[Lupus nephropathy treated with cyclosporine A. Report of 3 cases].
Topics: Adult; Cyclosporine; Female; Glomerulonephritis, Membranoproliferative; Humans; Immunosuppressive Agents; Lupus Erythematosus, Systemic | 1997 |
Update on immunosuppressive therapy.
Topics: Adult; Arthritis, Juvenile; Azathioprine; Behcet Syndrome; Child; Cladribine; Cyclophosphamide; Cyclosporine; Drug Therapy, Combination; Granulomatosis with Polyangiitis; Humans; Hydroxychloroquine; Immunosuppressive Agents; Liver; Lung; Lung Injury; Lupus Erythematosus, Systemic; Methotrexate; Pemphigoid, Benign Mucous Membrane; Retina; Tacrolimus; Thalidomide | 1998 |
Optic neuropathy in systemic lupus erythematosus and antiphospholipid syndrome (APS): clinical features, pathogenesis, review of the literature and proposed ophthalmological criteria for APS diagnosis.
Topics: Adult; Antibodies, Antinuclear; Antibodies, Antiphospholipid; Antiphospholipid Syndrome; Azathioprine; Cyclosporine; Diagnosis, Differential; Drug Therapy, Combination; Female; Humans; Lupus Erythematosus, Systemic; Middle Aged; Optic Nerve Diseases; Prednisolone; Visual Acuity | 1999 |
Cyclosporine for lupus membranous nephritis: experience with ten patients and review of the literature.
Topics: Adult; Cyclosporine; Female; Humans; Immunosuppressive Agents; Kidney Failure, Chronic; Lupus Erythematosus, Systemic; Lupus Nephritis; Male; Middle Aged; Treatment Outcome | 2000 |
[New fields of cyclosporin A (sandimmun) application in rheumatology: treatment of systemic lupus erythematosus].
Topics: B-Lymphocytes; Cyclosporine; Disease Progression; Humans; Immunosuppressive Agents; Interleukin-12; Interleukin-6; Lupus Erythematosus, Systemic; Macrophages; Rheumatology; Treatment Outcome | 2000 |
The treatment of lupus with cyclosporin A.
Topics: Cyclosporine; Humans; Immunosuppressive Agents; Lupus Erythematosus, Systemic | 2001 |
Combination treatment in autoimmune diseases: systemic lupus erythematosus.
Topics: Adrenal Cortex Hormones; Clinical Trials as Topic; Cyclosporine; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Meta-Analysis as Topic | 2001 |
Renal transplantation for systemic lupus erythematosus and recurrent lupus nephritis. A single-center experience and a review of the literature.
Topics: Adult; Animals; Antibodies, Antinuclear; Antilymphocyte Serum; Azathioprine; Complement System Proteins; Cyclosporine; Graft Survival; Humans; Immunosuppression Therapy; Kidney Transplantation; Lupus Erythematosus, Systemic; Lupus Nephritis; Male; Middle Aged; Muromonab-CD3; Prednisone; Rabbits | 1991 |
[New approaches to the therapy of diffuse inflammatory diseases of the connective tissue].
Topics: Adjuvants, Immunologic; Adrenal Cortex Hormones; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Connective Tissue Diseases; Cyclosporine; Drug Therapy, Combination; Humans; Lupus Erythematosus, Systemic; Lupus Nephritis; Lymph; Methotrexate; Plasmapheresis; Synovitis | 1991 |
16 trial(s) available for cyclosporine and Libman-Sacks Disease
| Article | Year |
|---|---|
Efficacy and safety of voclosporin versus placebo for lupus nephritis (AURORA 1): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial.
Topics: Adult; Aged; Calcineurin Inhibitors; Creatinine; Cyclosporine; Double-Blind Method; Female; Glomerular Filtration Rate; Glucocorticoids; Humans; Lupus Erythematosus, Systemic; Lupus Nephritis; Male; Middle Aged; Mycophenolic Acid; Treatment Outcome | 2021 |
Efficacy and safety of cyclosporine A in patients with refractory systemic lupus erythematosus in a daily clinical practice.
Topics: Adolescent; Adult; Aged; Cyclosporine; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Glucocorticoids; Humans; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Lupus Nephritis; Male; Middle Aged; Proteinuria; Severity of Illness Index; Survival Rate; Treatment Outcome; Young Adult | 2010 |
The BILAG multi-centre open randomized controlled trial comparing ciclosporin vs azathioprine in patients with severe SLE.
Topics: Adrenal Cortex Hormones; Adult; Azathioprine; Cyclosporine; Dose-Response Relationship, Drug; Female; Humans; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Male; Middle Aged; Prednisolone; Statistics as Topic; Sweden; Treatment Outcome; United Kingdom | 2010 |
Efficacy of cyclosporin-A in the long-term management of thrombocytopenia associated with systemic lupus erythematosus.
Topics: Adrenal Cortex Hormones; Adult; Aged; Cyclosporine; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Middle Aged; Prospective Studies; Secondary Prevention; Thrombocytopenia; Treatment Outcome | 2006 |
Prospective study of low-dose cyclosporine A in patients with refractory lupus nephritis.
Topics: Adolescent; Adult; Antirheumatic Agents; Cyclosporine; Dose-Response Relationship, Drug; Female; Glucocorticoids; Humans; Lupus Erythematosus, Systemic; Lupus Nephritis; Male; Middle Aged; Prednisolone; Prospective Studies; Treatment Outcome | 2007 |
Drug combination therapy of systemic lupus erythematosus.
Topics: Adult; Cyclosporine; Dexamethasone; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Immunoglobulin G; Interleukin-2; Kidney Function Tests; Lupus Erythematosus, Systemic; Male; Methotrexate; Receptors, Interleukin-2 | 1994 |
Use of cyclosporine in the treatment of autoimmune disorders.
Topics: Adult; Arthritis, Rheumatoid; Autoimmune Diseases; Cyclosporine; Female; Humans; Kidney; Lupus Erythematosus, Systemic; Male; Methotrexate; Myelodysplastic Syndromes; Recurrence | 1994 |
Effect of low-dose cyclosporin A on systemic lupus erythematosus disease activity.
Topics: Adult; Cyclosporine; Drug Administration Schedule; Female; Humans; Lupus Erythematosus, Systemic; Middle Aged; Prospective Studies; Severity of Illness Index | 1994 |
Cyclosporin A in the treatment of systemic lupus erythematosus: results of an open clinical study.
Topics: Adult; Cyclosporine; Female; Humans; Hypertension; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Male; Middle Aged; Pregnancy; Proteinuria; Treatment Outcome | 1996 |
Long-term treatment of systemic lupus erythematosus with cyclosporin A.
Topics: Adolescent; Adult; Blood Platelets; Creatinine; Cyclosporine; Disease Progression; Drug Administration Schedule; Female; Hematologic Tests; Humans; Immune System; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Male; Middle Aged; Proteinuria; Treatment Outcome | 1997 |
Cyclosporine and therapeutic plasma exchange in treatment of progressive autoimmune diseases.
Topics: Adrenal Cortex Hormones; Adult; Aged; Antibody Formation; Azathioprine; Behcet Syndrome; Combined Modality Therapy; Cyclophosphamide; Cyclosporine; Female; Humans; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Male; Middle Aged; Nephrotic Syndrome; Plasma Exchange; Prospective Studies; Proteinuria; Quality of Life | 1997 |
Neoral--new cyclosporin for old?
Topics: Adolescent; Adult; Anti-Inflammatory Agents; Antirheumatic Agents; Arthritis, Juvenile; Arthritis, Psoriatic; Arthritis, Rheumatoid; Behcet Syndrome; Biological Availability; Cyclosporine; Dose-Response Relationship, Drug; Drug Therapy; Emulsions; Humans; Lupus Erythematosus, Systemic; Middle Aged; Prednisolone; Rheumatic Diseases; Severity of Illness Index; Surveys and Questionnaires | 1997 |
Cyclosporin and plasmapheresis in treatment of progressive systemic lupus erythematosus (pSLE).
Topics: Adolescent; Adult; Cyclosporine; Female; Humans; Lupus Erythematosus, Systemic; Male; Middle Aged; Plasmapheresis; Treatment Outcome | 1997 |
Cyclosporine for lupus membranous nephritis: experience with ten patients and review of the literature.
Topics: Adult; Cyclosporine; Female; Humans; Immunosuppressive Agents; Kidney Failure, Chronic; Lupus Erythematosus, Systemic; Lupus Nephritis; Male; Middle Aged; Treatment Outcome | 2000 |
Cyclosporine-A plus steroids versus steroids alone in the 12-month treatment of systemic lupus erythematosus.
Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents; Cyclosporine; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Male; Middle Aged; Pilot Projects; Prednisolone; Prospective Studies; Remission Induction | 2000 |
[Chromosomal aberrations in lymphocytes of patients with systemic lupus erythematosus during cytostatic therapy].
Topics: Adolescent; Adult; Antineoplastic Agents, Alkylating; Chromosome Aberrations; Cyclophosphamide; Cyclosporine; Female; Humans; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Lymphocytes; Mutagenicity Tests | 2002 |
138 other study(ies) available for cyclosporine and Libman-Sacks Disease
| Article | Year |
|---|---|
Macrophage activation syndrome triggered by systemic lupus erythematosus flare: successful treatment with a combination of dexamethasone sodium phosphate, intravenous immunoglobulin, and cyclosporine: a case report.
Topics: Adult; Cyclosporine; Dexamethasone; Female; Humans; Immunoglobulins, Intravenous; Lupus Erythematosus, Systemic; Macrophage Activation Syndrome; Methylprednisolone | 2021 |
Case Report: Successful Treatment of Refractory Interstitial Lung Disease With Cyclosporine A and Pirfenidone in a Child With SLE.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Child, Preschool; Cyclosporine; Humans; Immunosuppressive Agents; Lung Diseases, Interstitial; Lupus Erythematosus, Systemic; Male; Pyridones | 2021 |
Will New Treatment Options for Lupus Nephritis Be Affordable?
Topics: Cyclosporine; Female; Humans; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Lupus Nephritis; Male; Mycophenolic Acid | 2022 |
Successful Discontinuation of Glucocorticoid Treatment after Administration of a Calcineurin Inhibitor for Nephrotic Syndrome in a Patient with Lupus Nephritis.
Topics: Adult; Aged; Calcineurin Inhibitors; Cyclosporine; Glucocorticoids; Humans; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Lupus Nephritis; Middle Aged; Nephrotic Syndrome; Prednisolone; Proteinuria | 2023 |
The efficacy and safety of cyclosporine in children with systemic lupus erythematosus: A protocol for systematic review and meta-analysis.
Topics: Child; Cyclosporine; Humans; Lupus Erythematosus, Systemic; Meta-Analysis as Topic; Research Design; Systematic Reviews as Topic | 2023 |
Ulcerative pyoderma gangrenosum.
Topics: Cyclosporine; Female; Humans; Immunosuppressive Agents; Leg; Lupus Erythematosus, Systemic; Middle Aged; Pyoderma Gangrenosum | 2019 |
Prevalence and predictors of flare after immunosuppressant discontinuation in patients with systemic lupus erythematosus in remission.
Topics: Adult; Antimalarials; Antirheumatic Agents; Azathioprine; Cyclosporine; Deprescriptions; Female; Humans; Hydroxychloroquine; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Maintenance Chemotherapy; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Proportional Hazards Models; Protective Factors; Recurrence; Remission Induction; Risk Factors; Symptom Flare Up; Time Factors | 2020 |
A Long-Term Follow-up of Retinal Vasculitis - Do They Develop Systemic Disease?
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Azathioprine; Colitis, Ulcerative; Cyclosporine; Drug Therapy, Combination; Female; Fluorescein Angiography; Follow-Up Studies; Glucocorticoids; Humans; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Male; Methotrexate; Middle Aged; Psoriasis; Recurrence; Retinal Vasculitis; Retrospective Studies; Tuberculin Test; Tuberculosis, Ocular; Visual Acuity; Vitreous Hemorrhage | 2020 |
Adult macrophage activation syndrome-haemophagocytic lymphohistiocytosis: 'of plasma exchange and immunosuppressive escalation strategies' - a single centre reflection.
Topics: Adrenal Cortex Hormones; Adult; Aged; Cyclosporine; Cytokines; Female; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Lymphohistiocytosis, Hemophagocytic; Macrophage Activation Syndrome; Male; Middle Aged; Plasma Exchange; Retrospective Studies; Sepsis; Still's Disease, Adult-Onset; Young Adult | 2020 |
String of successful trials in SLE: have we cracked the code?
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Calcineurin Inhibitors; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Cyclosporine; Humans; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Safety; Severity of Illness Index; Treatment Outcome | 2020 |
A case of γδ T-cell large granular lymphocytic leukemia due to a chronic active Epstein-Barr virus infection in systemic lupus erythematosus.
Topics: Antibodies, Viral; Chronic Disease; Cyclosporine; Diverticulitis; DNA, Viral; Drainage; Epstein-Barr Virus Infections; Female; Gene Rearrangement, T-Lymphocyte; Herpesvirus 4, Human; Humans; Immunocompromised Host; Immunosuppressive Agents; Intraepithelial Lymphocytes; Leukemia, Large Granular Lymphocytic; Leukopenia; Lumbar Vertebrae; Lupus Erythematosus, Systemic; Lymphocyte Count; Middle Aged; Prednisolone; Red-Cell Aplasia, Pure; Skin Diseases, Infectious; Spondylitis | 2020 |
COVID-19 infection in a northern-Italian cohort of systemic lupus erythematosus assessed by telemedicine.
Topics: Adult; Aged; Aged, 80 and over; Antirheumatic Agents; Azathioprine; Betacoronavirus; Clinical Laboratory Techniques; Cohort Studies; Coronavirus Infections; Cough; COVID-19; COVID-19 Testing; Cyclosporine; Diarrhea; Dysgeusia; Dyspnea; Fatigue; Female; Fever; Glucocorticoids; Humans; Hydroxychloroquine; Immunosuppressive Agents; Incidence; Intensive Care Units; Italy; Lupus Erythematosus, Systemic; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Olfaction Disorders; Pandemics; Pneumonia, Viral; Prednisone; Respiratory Distress Syndrome; SARS-CoV-2; Telemedicine | 2020 |
A highly potent lymphatic system-targeting nanoparticle cyclosporine prevents glomerulonephritis in mouse model of lupus.
Topics: Animals; Cyclosporine; Disease Models, Animal; Glomerulonephritis; Lupus Erythematosus, Systemic; Lymphatic System; Mice; Mice, Inbred MRL lpr; Nanoparticles | 2020 |
Targeted delivery of immunosuppressant in SLE.
Topics: Animals; Cyclosporine; Glomerulonephritis; Humans; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Lymphatic System; Mice; Nanoparticles | 2020 |
Successful treatment of subdural hemorrhage and retinal hemorrhage in childhood-onset systemic lupus erythematosus associated with thrombocytopenia: Case report.
Topics: Child; Cyclosporine; Female; Glucocorticoids; Hematoma, Subdural; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Methylprednisolone; Mycophenolic Acid; Purpura, Thrombocytopenic, Idiopathic; Retinal Hemorrhage | 2021 |
Voclosporin: a novel calcineurin inhibitor with no impact on mycophenolic acid levels in patients with SLE.
Topics: Area Under Curve; Calcineurin Inhibitors; Cyclosporine; Humans; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Mycophenolic Acid | 2022 |
COVID-19 in Patients with Multiple Sclerosis: Associations with Disease-Modifying Therapies.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Alemtuzumab; Azathioprine; Black or African American; Cladribine; Comorbidity; COVID-19; Crotonates; Cyclophosphamide; Cyclosporine; Databases, Factual; Dimethyl Fumarate; Female; Fingolimod Hydrochloride; Hospitalization; Humans; Hydroxybutyrates; Immunologic Factors; Immunosuppressive Agents; Incidence; Interferon-beta; Logistic Models; Lupus Erythematosus, Systemic; Male; Methotrexate; Middle Aged; Mitoxantrone; Multiple Sclerosis; Mycophenolic Acid; Natalizumab; Nitriles; Obesity; Risk Factors; Rituximab; SARS-CoV-2; Toluidines; United States; White People; Young Adult | 2021 |
Efficacy of cyclosporine in a patient with lupus mesenteric vasculitis refractory to conventional immunosuppressive therapy.
Topics: Adult; Cyclosporine; Female; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Mesentery; Peritoneal Diseases; Splanchnic Circulation; Vasculitis | 2021 |
Cyclosporine for the treatment of lupus nephritis in patients with systemic lupus erythematosus.
Topics: Adult; Biopsy; Cyclosporine; Disease Progression; Dose-Response Relationship, Drug; Female; Glomerular Filtration Rate; Humans; Immunosuppressive Agents; Kidney; Lupus Erythematosus, Systemic; Lupus Nephritis; Male; Recurrence; Remission Induction; Retrospective Studies; Treatment Outcome; Young Adult | 2018 |
Pyoderma gangrenosum masquerading as an ulcer related to antiphospholipid antibodies in a patient with systemic lupus erythematosus.
Topics: Antibodies, Antiphospholipid; Antiphospholipid Syndrome; Cyclosporine; Female; Humans; Lupus Erythematosus, Systemic; Middle Aged; Prednisolone; Pyoderma Gangrenosum; Skin; Skin Transplantation; Ulcer | 2018 |
A rare and serious cause of pancytopenia in a patient with systemic lupus erythematosus: haemophagocytic lymphohistiocytosis.
Topics: Anti-Inflammatory Agents; Antineoplastic Agents, Phytogenic; Cyclosporine; Dexamethasone; Etoposide; Female; Ferritins; Humans; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Lymphohistiocytosis, Hemophagocytic; Middle Aged; Pancytopenia; Patient Comfort; Treatment Outcome | 2018 |
Bisphosphonate-induced orbital inflammation in a patient on chronic immunosuppressive therapy.
Topics: Administration, Oral; Bone Density Conservation Agents; Cyclosporine; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Infusions, Intravenous; Lupus Erythematosus, Systemic; Magnetic Resonance Imaging; Middle Aged; Orbital Pseudotumor; Osteoporosis, Postmenopausal; Polyradiculoneuropathy, Chronic Inflammatory Demyelinating; Prednisone; Sjogren's Syndrome; Zoledronic Acid | 2019 |
Systemic lupus erythematosus with cytophagic histiocytic panniculitis successfully treated with high-dose glucocorticoids and cyclosporine A.
Topics: Adult; Cyclosporine; Glucocorticoids; Histiocytes; Humans; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Male; Panniculitis | 2013 |
Successful treatment of class IV+V lupus nephritis with combination therapy of high-dose corticosteroids, tacrolimus and intravenous cyclophosphamide.
Topics: Adolescent; Antihypertensive Agents; Biphenyl Compounds; Cyclophosphamide; Cyclosporine; Drug Therapy, Combination; Female; Humans; Hypertension, Renal; Immunosuppressive Agents; Infusions, Intravenous; Irbesartan; Lupus Erythematosus, Systemic; Lupus Nephritis; Nephrotic Syndrome; Prednisolone; Pulse Therapy, Drug; Recurrence; Ribonucleosides; Severity of Illness Index; Tacrolimus; Tetrazoles | 2013 |
Refractory macrophage activation syndrome in a patient with SLE and APLA syndrome - Successful use of PET- CT and Anakinra in its diagnosis and treatment.
Topics: Adult; Antiphospholipid Syndrome; Antirheumatic Agents; Cyclosporine; Female; Humans; Interleukin 1 Receptor Antagonist Protein; Lupus Erythematosus, Systemic; Macrophage Activation Syndrome; Tomography, X-Ray Computed; Treatment Outcome | 2015 |
Reduced carotid intima-media thickness in systemic lupus erythematosus patients treated with cyclosporine A.
Topics: Adult; Atherosclerosis; Carotid Arteries; Carotid Artery Diseases; Carotid Intima-Media Thickness; Cyclosporine; Female; Humans; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Male; Middle Aged; Risk Factors | 2014 |
Hemophagocytic syndrome diagnosed by liver biopsy in a female patient with systemic lupus erythematosus.
Topics: Anti-Inflammatory Agents; Cyclosporine; Disease Progression; Female; Humans; Liver; Lupus Erythematosus, Systemic; Lymphohistiocytosis, Hemophagocytic; Methylprednisolone; Prednisolone; Young Adult | 2013 |
Time to recovery from proteinuria in patients with lupus nephritis receiving standard treatment.
Topics: Adolescent; Adult; Antineoplastic Agents; Cyclosporine; Databases, Factual; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Kaplan-Meier Estimate; Longitudinal Studies; Lupus Erythematosus, Systemic; Lupus Nephritis; Male; Methotrexate; Middle Aged; Ontario; Predictive Value of Tests; Proportional Hazards Models; Prospective Studies; Proteinuria; Steroids; Time Factors; Treatment Outcome; Urinalysis; Young Adult | 2014 |
Increased serum fibroblast growth factor-23 and decreased bone turnover in patients with systemic lupus erythematosus under treatment with cyclosporine and steroid but not steroid only.
Topics: Absorptiometry, Photon; Adult; Biomarkers; Bone Diseases, Metabolic; Bone Remodeling; Case-Control Studies; Cross-Sectional Studies; Cyclosporine; Female; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Glucocorticoids; Humans; Immunosuppressive Agents; Lumbar Vertebrae; Lupus Erythematosus, Systemic; Male; Middle Aged; Osteoporosis; Premenopause; Treatment Outcome | 2015 |
Macrophage activation syndrome in a newborn infant born to a mother with autoimmune disease.
Topics: Adult; Antirheumatic Agents; Cyclosporine; Early Diagnosis; Female; Glucocorticoids; Humans; Immunoglobulins, Intravenous; Infant, Newborn; Lupus Erythematosus, Systemic; Macrophage Activation Syndrome; Maternal-Fetal Exchange; Pregnancy; Still's Disease, Adult-Onset; Treatment Outcome | 2015 |
Characteristics and outcome of autoimmune liver disease in Asian children.
Topics: Adolescent; Anti-Inflammatory Agents; Asian People; Azathioprine; Child; Child, Preschool; Cholangitis, Sclerosing; Cyclosporine; Delayed Diagnosis; Female; Follow-Up Studies; Hepatitis, Autoimmune; Humans; Immunosuppressive Agents; Infant; Inflammatory Bowel Diseases; Liver Cirrhosis; Liver Transplantation; Lupus Erythematosus, Systemic; Malaysia; Male; Prednisolone; Retrospective Studies; Survival Rate; Time-to-Treatment; Treatment Outcome | 2015 |
Therapeutic drug monitoring of cyclosporine microemulsion in patients with corticosteroid-resistant systemic lupus erythematosus.
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Cyclosporine; Drug Monitoring; Female; Humans; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Male; Middle Aged; Retrospective Studies; Time Factors; Young Adult | 2015 |
Liver injury correlates with biomarkers of autoimmunity and disease activity and represents an organ system involvement in patients with systemic lupus erythematosus.
Topics: Acetylcysteine; Adult; Alanine Transaminase; Antibodies, Antinuclear; Aspartate Aminotransferases; Azathioprine; Biomarkers; Cohort Studies; Complement System Proteins; Cyclosporine; Diabetes Mellitus; Female; Free Radical Scavengers; Humans; Immunosuppressive Agents; Liver Diseases; Longitudinal Studies; Lupus Erythematosus, Systemic; Male; Middle Aged; Mycophenolic Acid; Prednisone; Prevalence; Retrospective Studies; Severity of Illness Index; Sex Distribution; Sirolimus | 2015 |
Allogeneic Hematopoietic Stem Cell Transplantation in the Treatment of Human C1q Deficiency: The Karolinska Experience.
Topics: Adolescent; Adult; Child; Child, Preschool; Complement C1q; Cortisone; Cyclosporine; Fatal Outcome; Female; Gastrointestinal Diseases; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Heterozygote; Humans; Infant; Iraq; Lupus Erythematosus, Systemic; Lymphoproliferative Disorders; Male; Methotrexate; Postoperative Complications; Rituximab; Sweden; Time Factors; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome | 2016 |
Prevalence of premature ovarian failure in systemic lupus erythematosus patients treated with immunosuppressive agents in Thailand.
Topics: Adolescent; Adult; Chi-Square Distribution; Cross-Sectional Studies; Cyclosporine; Dose-Response Relationship, Drug; Female; Humans; Immunosuppressive Agents; Logistic Models; Lupus Erythematosus, Systemic; Prevalence; Primary Ovarian Insufficiency; Risk Assessment; Risk Factors; Thailand; Time Factors; Young Adult | 2016 |
Macrophage activation syndrome in children with systemic juvenile idiopathic arthritis and systemic lupus erythematosus.
Topics: Adolescent; Adrenal Cortex Hormones; Arthritis, Juvenile; Child; Child, Preschool; Cyclosporine; Fatigue; Female; Humans; Immunosuppressive Agents; Infant; Lupus Erythematosus, Systemic; Macrophage Activation Syndrome; Male; Retrospective Studies; Treatment Outcome | 2016 |
Warm antibody hemolytic anemia-a rare presentation of neonatal lupus.
Topics: Anemia, Hemolytic, Autoimmune; Breast Feeding; Cyclosporine; Humans; Infant; Infant, Newborn; Lupus Erythematosus, Systemic; Male; Treatment Outcome | 2017 |
Decreased Vision and Cognitive Decline.
Topics: Adult; Antibiotics, Antineoplastic; Cognitive Dysfunction; Cyclosporine; Drug Therapy, Combination; Fluorescein Angiography; Glucocorticoids; Humans; Immunosuppressive Agents; Infusions, Intravenous; Lupus Erythematosus, Systemic; Male; Methylprednisolone; Mycophenolic Acid; Retinal Vasculitis; Vision, Low; Visual Acuity | 2016 |
[The clinical characteristics of macrophage activation syndrome secondary to systemic lupus erythematosus].
Topics: Adult; Cyclophosphamide; Cyclosporine; Female; Fever; Glucocorticoids; Humans; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Macrophage Activation Syndrome; Male; Middle Aged; Mycophenolic Acid; Retrospective Studies; Thrombocytopenia; Treatment Outcome | 2016 |
Macrophage activation syndrome as initial presentation of systemic lupus erythematosus.
Topics: Adolescent; Antibodies, Antinuclear; Cyclosporine; Female; Humans; Immune System Diseases; Lupus Erythematosus, Systemic; Lymphohistiocytosis, Hemophagocytic; Macrophage Activation; Rheumatic Diseases; Syndrome | 2008 |
A 32-year-old woman with arthralgias and severe hypotension.
Topics: Adult; Arthralgia; Cyclosporine; Diagnosis, Differential; Female; Humans; Hypotension; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Mycophenolic Acid; Myocarditis; Treatment Outcome | 2008 |
Cyclosporine use in miscellaneous clinical settings other than organ transplantations: is there any evidence for target levels?
Topics: Adolescent; Adult; Autoimmune Diseases; Child; Child, Preschool; Cyclosporine; Dermatitis, Atopic; Dermatomyositis; Female; Humans; Lupus Erythematosus, Systemic; Male; Middle Aged; Monitoring, Physiologic; Purpura, Thrombocytopenic, Idiopathic; Transplantation Immunology; Young Adult | 2008 |
Systemic lupus erythematosus presenting as pyoderma gangrenosum in two cases.
Topics: Adult; Anti-Inflammatory Agents; Antibodies, Antineutrophil Cytoplasmic; Antibodies, Antiphospholipid; Cicatrix, Hypertrophic; Cyclosporine; Female; Humans; Hydroxychloroquine; Lupus Erythematosus, Systemic; Middle Aged; Prednisolone; Pyoderma Gangrenosum; Skin; Treatment Outcome; Ulcer | 2009 |
A reversible cause of blindness that should not be forgotten: cyclosporine-induced posterior reversible encephalopathy syndrome.
Topics: Adult; Blindness; Brain Diseases; Cyclosporine; Female; Humans; Lupus Erythematosus, Systemic; Neurotoxicity Syndromes | 2009 |
Isoniazid-triggered pure red cell aplasia in systemic lupus erythematosus complicated with myasthenia gravis.
Topics: Antitubercular Agents; Cyclosporine; Drug Therapy, Combination; Erythroblasts; Female; Humans; Immunosuppressive Agents; Iron; Isoniazid; Lupus Erythematosus, Systemic; Middle Aged; Myasthenia Gravis; Red-Cell Aplasia, Pure; Reticulocyte Count; Reticulocytes; Treatment Outcome | 2010 |
Acute generalized exanthematous pustulosis and toxic epidermal necrolysis induced by hydroxychloroquine.
Topics: Aged; Antirheumatic Agents; Azathioprine; Cyclosporine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Hydroxychloroquine; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Skin Diseases, Vesiculobullous; Stevens-Johnson Syndrome; Treatment Outcome | 2009 |
An unusual case of loin pain and nephritis.
Topics: Adolescent; Cyclosporine; DNA; Enoxaparin; Female; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Low Back Pain; Lupus Erythematosus, Systemic; Nephrotic Syndrome; Prednisolone; Proteinuria; Renal Veins; Venous Thrombosis | 2010 |
Serum BLC/CXCL13 concentrations and renal expression of CXCL13/CXCR5 in patients with systemic lupus erythematosus and lupus nephritis.
Topics: Adolescent; Adult; Aged; Animals; Antigens, CD19; Antirheumatic Agents; Azathioprine; B-Lymphocytes; Chemokine CXCL13; Cyclosporine; Female; Humans; Kidney; Lupus Erythematosus, Systemic; Lupus Nephritis; Male; Mice; Middle Aged; Receptors, CXCR5; T-Lymphocytes; Young Adult | 2010 |
Calcinosis cutis universalis with pediatric systemic lupus erythematosus.
Topics: Administration, Oral; Antiphospholipid Syndrome; Aspirin; Calcinosis; Child; Cyclosporine; Dermatologic Agents; Diltiazem; Drug Therapy, Combination; Enoxaparin; Fibrinolytic Agents; Glomerulonephritis, Membranoproliferative; Glucocorticoids; Humans; Lupus Erythematosus, Systemic; Male; Skin Ulcer; Treatment Outcome | 2010 |
Type B insulin resistance complicated with systemic lupus erythematosus.
Topics: Autoantibodies; Cyclophosphamide; Cyclosporine; Drug Therapy, Combination; Glucose Intolerance; Humans; Immunosuppressive Agents; Insulin Resistance; Lupus Erythematosus, Systemic; Male; Middle Aged; Prednisolone; Receptor, Insulin | 2010 |
Multiple dermatofibromas in a patient with systemic lupus erythematosus and Sjögren's syndrome.
Topics: Adult; Cyclosporine; Glucocorticoids; Histiocytoma, Malignant Fibrous; Humans; Immunocompromised Host; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Male; Prednisone; Sjogren's Syndrome; Skin Neoplasms | 2010 |
Measurement of interleukin-1 receptor antagonist in patients with systemic lupus erythematosus could predict renal manifestation of the disease.
Topics: Adult; beta 2-Glycoprotein I; Biomarkers; C-Reactive Protein; Creatinine; Cyclophosphamide; Cyclosporine; Female; Glomerular Filtration Rate; Humans; Interleukin 1 Receptor Antagonist Protein; Lupus Erythematosus, Systemic; Lupus Nephritis; Male; Metabolic Clearance Rate; Methylprednisolone; Middle Aged; Proteinuria; Severity of Illness Index; Young Adult | 2010 |
Anti-S alloantibody underlying pan agglutinating autoantibody in a patient of systemic lupus erythematosus: a case report.
Topics: Adult; Autoantibodies; Cyclosporine; Female; Humans; Immunosuppressive Agents; Isoantibodies; Lupus Erythematosus, Systemic; Steroids; Treatment Outcome | 2011 |
Treatment with cyclosporine A improves SLE disease activity of Japanese patients with diffuse proliferative lupus nephritis.
Topics: Adult; Cyclosporine; Female; Humans; Immunosuppressive Agents; Japan; Kidney; Kidney Function Tests; Lupus Erythematosus, Systemic; Lupus Nephritis; Male; Middle Aged; Proteinuria; Treatment Outcome; Young Adult | 2011 |
Etanercept for the treatment of intractable hemophagocytic syndrome with systemic lupus erythematosus.
Topics: Adult; Cyclosporine; Drug Therapy, Combination; Etanercept; Female; Glucocorticoids; Humans; Immunoglobulin G; Immunoglobulins, Intravenous; Immunosuppressive Agents; Injections, Subcutaneous; Lupus Erythematosus, Systemic; Lymphohistiocytosis, Hemophagocytic; Methotrexate; Prednisolone; Pulse Therapy, Drug; Receptors, Tumor Necrosis Factor; Remission Induction; Treatment Failure | 2012 |
Successful treatment of Rowell syndrome using oral cyclosporine A.
Topics: Administration, Oral; Cyclosporine; Erythema Multiforme; Humans; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Male; Middle Aged; Skin; Syndrome; Treatment Outcome | 2011 |
A case of steroid-resistant nephrotic syndrome associated with systemic lupus erythematosus.
Topics: Child; Cyclosporine; Drug Resistance; Female; Glucocorticoids; Humans; Lupus Erythematosus, Systemic; Methylprednisolone; Nephrotic Syndrome | 2014 |
Hematological features of pediatric systemic lupus erythematosus: suggesting management strategies in children.
Topics: Adolescent; Anemia, Hemolytic; Antibodies; Anticoagulants; Antiphospholipid Syndrome; Cardiolipins; Child; Child, Preschool; Cyclosporine; Female; Heparin, Low-Molecular-Weight; Humans; Immunoglobulins, Intravenous; Immunologic Factors; Immunosuppressive Agents; Leukopenia; Lupus Erythematosus, Systemic; Macrophage Activation Syndrome; Male; Phospholipids; Plasma Exchange; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Steroids; Thrombotic Microangiopathies; Venous Thrombosis | 2012 |
Clinical analysis of macrophage activation syndrome in pediatric patients with autoimmune diseases.
Topics: Adolescent; Antiphospholipid Syndrome; Arthritis, Juvenile; Autoimmune Diseases; Child; Cyclosporine; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Macrophage Activation Syndrome; Male; Methylprednisolone; Retrospective Studies; Treatment Outcome | 2012 |
Protein-losing enteropathy and premature ovarian failure in a young woman with systemic lupus erythematosus.
Topics: Adult; Cyclosporine; Female; Humans; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Oophoritis; Polyendocrinopathies, Autoimmune; Primary Ovarian Insufficiency; Protein-Losing Enteropathies; Treatment Outcome | 2012 |
Macrophage activation syndrome in children with systemic lupus erythematosus and children with juvenile idiopathic arthritis.
Topics: Adolescent; Arthritis, Juvenile; Child; Child, Preschool; Cohort Studies; Cyclophosphamide; Cyclosporine; Female; Hospital Mortality; Humans; Infant; Infant, Newborn; Inpatients; Intensive Care Units, Pediatric; Interleukin-1; Lupus Erythematosus, Systemic; Macrophage Activation Syndrome; Male; Mycophenolic Acid; Retrospective Studies; Treatment Outcome | 2012 |
IV cyclosporine to treat refractory CVID enteropathy.
Topics: Administration, Intravenous; Adult; Common Variable Immunodeficiency; Cyclosporine; Diarrhea; Female; Humans; Immunosuppressive Agents; Lupus Erythematosus, Systemic | 2012 |
Systemic lupus erythematosus with haemophagocytosis and severe liver disorder.
Topics: Adult; Anti-Inflammatory Agents; Cyclosporine; Cytomegalovirus Infections; Drug Therapy, Combination; Female; Histiocytosis, Non-Langerhans-Cell; Humans; Immunosuppressive Agents; Liver Diseases; Lupus Erythematosus, Systemic; Prednisolone | 2002 |
CD40L overexpression on T cells and monocytes from patients with systemic lupus erythematosus is resistant to calcineurin inhibition.
Topics: Adult; Aged; Calcineurin; Calcineurin Inhibitors; Calcium; CD40 Ligand; Cyclosporine; Dexamethasone; Female; Humans; In Vitro Techniques; Lupus Erythematosus, Systemic; Middle Aged; Monocytes; Muromonab-CD3; T-Lymphocytes; Up-Regulation | 2002 |
The immune development in a child born to a cyclosporin A-treated woman with systemic lupus erythematosus/polymyositis.
Topics: Adolescent; Cyclosporine; Female; Humans; Immune System; Immunosuppressive Agents; Infant, Newborn; Infant, Premature; Lupus Erythematosus, Systemic; Polymyositis; Pregnancy; Pregnancy Complications; Prenatal Exposure Delayed Effects | 2002 |
Pneumococcal sepsis in a girl with systemic lupus erythematosus.
Topics: Child; Cyclosporine; Fatal Outcome; Female; Fingers; Glucocorticoids; Humans; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Pneumococcal Infections; Sepsis; Toes | 2003 |
Aplastic anemia complicating systemic lupus erythematosus: successful management with cyclosporine.
Topics: Adult; Anemia, Aplastic; Cyclophosphamide; Cyclosporine; Female; Humans; Lupus Erythematosus, Systemic; Menorrhagia; Methylprednisolone; Pancytopenia; Phenytoin; Seizures; Treatment Outcome | 2004 |
Treatment of steroid-resistant systemic lupus erythematosus with extremely low dose of cyclosporine A.
Topics: Child; Cyclosporine; Dose-Response Relationship, Drug; Drug Resistance; Female; Humans; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Steroids; Treatment Outcome | 2004 |
Tacrolimus and pure red-cell aplasia.
Topics: Adult; Cyclosporine; Female; Humans; Immunosuppressive Agents; Kidney Failure, Chronic; Kidney Transplantation; Lupus Erythematosus, Systemic; Male; Mycophenolic Acid; Red-Cell Aplasia, Pure; Tacrolimus | 2005 |
Standard chronic immunosuppression after kidney transplantation for systemic lupus erythematosus eliminates recurrence of disease.
Topics: Adult; Calcineurin Inhibitors; Cyclosporine; Female; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Kidney Transplantation; Lupus Erythematosus, Systemic; Lupus Nephritis; Male; Middle Aged; Secondary Prevention; Severity of Illness Index; Tacrolimus | 2005 |
T-cell-mediated pure red-cell aplasia in systemic lupus erythematosus: response to cyclosporin A and mycophenolate mofetil.
Topics: Adult; Autoimmunity; Cyclosporine; Female; Humans; Lupus Erythematosus, Systemic; Mycophenolic Acid; Red-Cell Aplasia, Pure; T-Lymphocytes | 2005 |
Maintenance immunosuppression use and the associated risk of avascular necrosis after kidney transplantation in the United States.
Topics: Adult; Cyclosporine; Diabetes Mellitus; Female; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Kidney Transplantation; Lupus Erythematosus, Systemic; Male; Medicare; Middle Aged; Necrosis; Postoperative Complications; Regression Analysis; Sirolimus; Survival Analysis; United States | 2005 |
Causes of acute thrombotic microangiopathy in patients receiving kidney transplantation.
Topics: Acute Disease; Adult; Antiphospholipid Syndrome; Cyclosporine; Female; Humans; Immunosuppressive Agents; Kidney Transplantation; Lupus Erythematosus, Systemic; Male; Microcirculation; Middle Aged; Postoperative Period; Retrospective Studies; Tacrolimus; Thrombosis | 2004 |
Systemic lupus erythematosus with refractory hemolytic anemia effectively treated with cyclosporin A: a case report.
Topics: Anemia, Hemolytic, Autoimmune; Cyclosporine; Female; Glucocorticoids; Hemoglobins; Humans; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Middle Aged; Prednisolone | 2005 |
Reversible posterior leukoencephalopathy syndrome in systemic lupus erythematosus: what can this teach us?
Topics: Cyclosporine; Drug Approval; Humans; Hypertensive Encephalopathy; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Product Surveillance, Postmarketing; Seizures; Thrombocytopenia | 2005 |
Reversible posterior leukoencephalopathy syndrome in systemic lupus erythematosus with thrombocytopenia treated with cyclosporine.
Topics: Adult; Brain; Cyclosporine; Female; Glucocorticoids; Humans; Hypertensive Encephalopathy; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Magnetic Resonance Imaging; Prednisolone; Seizures; Thrombocytopenia; Vincristine | 2005 |
[Clinical experiences with cyclosporin A in patients with systemic lupus erythematosus].
Topics: Adult; Cyclosporine; Female; Humans; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Male; Middle Aged; Prospective Studies; Retrospective Studies; Treatment Outcome | 2005 |
[Burkitt's lymphoma in a patient with systemic lupus erythematosus treated with immunosuppressive drugs. A case report].
Topics: Adult; Biopsy; Bone Marrow; Burkitt Lymphoma; Cyclophosphamide; Cyclosporine; Fatal Outcome; Female; Humans; Immunosuppressive Agents; Lupus Erythematosus, Systemic | 2006 |
Abnormal intracellular distribution of NFAT1 in T lymphocytes from patients with systemic lupus erythematosus and characteristic clinical features.
Topics: Adult; Aged; Cyclosporine; Female; Humans; I-kappa B Proteins; Lupus Erythematosus, Systemic; Male; Middle Aged; NFATC Transcription Factors; T-Lymphocytes | 2006 |
Coexisting subacute and systemic lupus erythematosus after terbinafine administration: successful treatment with mycophenolate mofetil.
Topics: Acute Disease; Adult; Antifungal Agents; Cyclosporine; Female; Humans; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Methylprednisolone; Mycophenolic Acid; Naphthalenes; Onychomycosis; Terbinafine | 2006 |
Effective treatment with cyclosporine A of a child with systemic lupus erythematosus resistant to cyclophosphamide pulse therapy.
Topics: Child; Cyclophosphamide; Cyclosporine; Drug Resistance; Female; Humans; Immunosuppressive Agents; Injections, Intravenous; Lupus Erythematosus, Systemic; Pulse Therapy, Drug; Treatment Outcome | 2006 |
The dynamism of cutaneous lupus erythematosus: mild discoid lupus erythematosus evolving into SLE with SCLE and treatment-resistant lupus panniculitis.
Topics: Antimalarials; Azathioprine; Cyclophosphamide; Cyclosporine; Disease Progression; Drug Therapy, Combination; Female; Humans; Hydroxychloroquine; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Methotrexate; Methylprednisolone; Middle Aged; Panniculitis, Lupus Erythematosus; Pulse Therapy, Drug; Tacrolimus; Treatment Failure | 2007 |
Characteristics and long-term outcome of 15 episodes of systemic lupus erythematosus-associated hemophagocytic syndrome.
Topics: Adolescent; Adult; C-Reactive Protein; Child; Cyclophosphamide; Cyclosporine; Disease Progression; Episode of Care; Female; Humans; Intensive Care Units; Lupus Erythematosus, Systemic; Lymphohistiocytosis, Hemophagocytic; Male; Methylprednisolone; Prednisone; Prognosis; Retrospective Studies; Time Factors; Treatment Outcome | 2006 |
A serological switching from anti-dsDNA to anti-Sm antibodies coincided with severe clinical manifestations of systemic lupus erythematosus (hemophagocytosis, profundus and psychosis).
Topics: Administration, Oral; Antibodies, Antinuclear; Antibody Specificity; Autoantibodies; Autoantigens; Cyclosporine; Disease Progression; DNA; Drug Therapy, Combination; Fever; Humans; Immunosuppressive Agents; Infusions, Intravenous; Interleukin-6; Lupus Erythematosus, Systemic; Lymphohistiocytosis, Hemophagocytic; Memory Disorders; Methylprednisolone; Prednisolone; Psychotic Disorders; Ribonucleoproteins, Small Nuclear; Skin; snRNP Core Proteins | 2007 |
Expression of messenger RNA for transforming growth factor-beta1 and for transforming growth factor-beta receptors in peripheral blood of systemic lupus erythematosus patients treated with low doses of quinagolide.
Topics: Adolescent; Adult; Aminoquinolines; Azathioprine; Cyclosporine; Dopamine Agonists; Dose-Response Relationship, Drug; Female; Humans; Lupus Erythematosus, Systemic; Middle Aged; Prednisone; Receptors, Transforming Growth Factor beta; RNA, Messenger; Transforming Growth Factor beta1 | 2007 |
Prolactin and autoimmune diseases in humans.
Topics: Aminoquinolines; Animals; Arthritis, Rheumatoid; Autoimmune Diseases; Bromocriptine; Cabergoline; Cyclosporine; Dopamine Agonists; Double-Blind Method; Drug Therapy, Combination; Ergolines; Female; Humans; Hyperprolactinemia; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Male; Mice; Mice, Knockout; Penicillamine; Prednisone; Prolactin; Rats; Receptors, Prolactin | 2007 |
A case of a pregnant woman developing systemic lupus erythematosus during pregnancy.
Topics: Adult; Cyclosporine; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Lupus Nephritis; Prednisolone; Pregnancy; Pregnancy Complications; Pregnancy Outcome | 2007 |
Successful treatment of refractory thrombotic thrombocytopenic purpura with cyclosporine and corticosteroids in a patient with systemic lupus erythematosus and antibodies to ADAMTS13.
Topics: ADAM Proteins; Antibody Formation; Blood Chemical Analysis; Cyclosporine; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Lupus Erythematosus, Systemic; Methylprednisolone; Middle Aged; Purpura, Thrombotic Thrombocytopenic; Recurrence; Risk Assessment; Severity of Illness Index; Treatment Outcome | 2007 |
Immune function in children born to mothers with autoimmune diseases and exposed in utero to immunosuppressants.
Topics: Antigens, CD; Autoimmune Diseases; Azathioprine; Cyclosporine; Cytokines; Dexamethasone; Female; Humans; Immunophenotyping; Immunosuppressive Agents; Infant, Newborn; Lupus Erythematosus, Systemic; Lymphocytes; Male; Pregnancy; Pregnancy Complications | 2007 |
Potential effects of cyclosporin A on coronary vasomotor function in young patients with systemic lupus erythematosus: comment on the article by Hirata et al.
Topics: Age Factors; Antirheumatic Agents; Coronary Disease; Coronary Vessels; Cyclosporine; Humans; Lupus Erythematosus, Systemic | 2008 |
Cavitary lung lesion in a patient with systemic lupus erythematosus: an unusual manifestation of cytomegalovirus pneumonitis.
Topics: Adult; Cyclosporine; Cytomegalovirus Infections; Female; Humans; Immunocompromised Host; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Opportunistic Infections; Pneumonia; Radiography; Steroids | 2008 |
Efficacy of cyclosporine therapy for systemic lupus erythematosus in childhood.
Topics: Adolescent; Child; Cyclosporine; Female; Humans; Immunosuppressive Agents; Lupus Erythematosus, Systemic | 2008 |
P-glycoprotein functions in peripheral-blood CD4+ cells of patients with systemic lupus erythematosus.
Topics: Adult; Anti-Inflammatory Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; CD3 Complex; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cyclosporine; Drug Resistance; Female; Fluorescent Dyes; Glucocorticoids; Humans; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Male; Middle Aged; Prednisone; Rhodamines | 2008 |
B cell depletion and a T cell-targeted therapy allows to control the sudden onset of diabetes and lupus, without steroids.
Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antirheumatic Agents; B-Lymphocytes; Combined Modality Therapy; Cyclosporine; Diabetes Mellitus, Type 1; Drug Delivery Systems; Female; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Leukapheresis; Lupus Erythematosus, Systemic; Rituximab; T-Lymphocytes; Treatment Outcome | 2008 |
[A case of Felty's syndrome with marked thrombocytopenia and severe hypocomplementemia].
Topics: Antirheumatic Agents; Complement System Proteins; Cyclosporine; Diagnosis, Differential; Felty Syndrome; Female; Humans; Lupus Erythematosus, Systemic; Middle Aged; Thrombocytopenia | 1995 |
Clinical problem solving. The girl with the curl.
Topics: Acyclovir; Antitubercular Agents; Cyclosporine; Female; Fever; Herpesvirus 4, Human; Humans; Immunosuppression Therapy; Kidney Transplantation; Lupus Erythematosus, Systemic; Lupus Nephritis; Lymphoma; Middle Aged; Prednisone | 1995 |
[Cyclosporin therapy of patients with systemic lupus erythematosus].
Topics: Adrenal Cortex Hormones; Adult; Cyclophosphamide; Cyclosporine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Lupus Erythematosus, Systemic; Lupus Nephritis; Male; Nephrotic Syndrome; Remission Induction; Thrombocytopenia | 1994 |
Cyclosporin A in the treatment of systemic lupus erythematosus: comment on the article by Tokuda et al.
Topics: Cyclosporine; Humans; Hypertension; Kidney; Lupus Erythematosus, Systemic | 1994 |
Post-infantile giant cell hepatitis in an elderly female patient with systemic lupus erythematosus.
Topics: Aged; Azathioprine; Cyclosporine; Female; Giant Cells; Hepatitis, Viral, Human; Humans; Liver; Lupus Erythematosus, Systemic; Parainfluenza Virus 3, Human; Paramyxoviridae Infections; Prednisolone | 1994 |
Rapamycin prolongs survival and arrests pathophysiologic changes in murine systemic lupus erythematosus.
Topics: Administration, Oral; Albuminuria; Animals; Antibodies, Antinuclear; Cyclosporine; Female; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Mice; Mice, Mutant Strains; Polyenes; Sirolimus; Survival Analysis | 1994 |
Pulmonary arterial hypertension responsive to immunosuppressive therapy in systemic lupus erythematosus.
Topics: Adult; Blood Pressure; Cyclosporine; Dexamethasone; Drug Therapy, Combination; Echocardiography, Doppler; Female; Fluocortolone; Humans; Hypertension, Pulmonary; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Methotrexate; Pulmonary Artery | 1993 |
Primary ascites as the presenting feature of systemic lupus erythematosus: response to cyclosporin therapy.
Topics: Adult; Ascites; Cyclosporine; Female; Humans; Immunosuppressive Agents; Lupus Erythematosus, Systemic | 1995 |
Sub-therapeutic doses of sirolimus and cyclosporin A in combination reduce SLE pathologies in the MRL mouse.
Topics: Animals; Cyclosporine; Enzyme-Linked Immunosorbent Assay; Female; Immunosuppressive Agents; Interleukin-2; Lupus Erythematosus, Systemic; Mice; Mice, Inbred Strains; Polyenes; Sirolimus; Spleen | 1995 |
[Macrophage activation syndrome. Cutaneous manifestations].
Topics: Arthritis, Juvenile; Bone Marrow; Cyclosporine; Humans; Lupus Erythematosus, Systemic; Macrophage Activation; Phagocytosis; Skin Diseases; Syndrome | 1995 |
Cyclosporine therapy for acquired factor VIII inhibitor in a patient with systemic lupus erythematosus.
Topics: Adult; Autoantibodies; Cyclosporine; Factor VIII; Female; Humans; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Male; Middle Aged | 1996 |
Effect of 1 year cyclosporine A treatment on the activity and renal involvement of systemic lupus erythematosus: a pilot study.
Topics: Adult; Biopsy; Cyclosporine; Female; Humans; Immunosuppressive Agents; Kidney; Kidney Diseases; Lupus Erythematosus, Systemic; Male; Methylprednisolone; Middle Aged; Pilot Projects | 1998 |
Effect of extremely low dose cyclosporine treatment on the thrombocytopenia in systemic lupus erythematosus.
Topics: Adult; Cyclosporine; Female; Humans; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Thrombocytopenia | 1998 |
Chronic interstitial cystitis and systemic lupus erythematosus in an 8-year-old girl.
Topics: Brain; Child; Chronic Disease; Cyclosporine; Cystitis, Interstitial; Female; Humans; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Magnetic Resonance Imaging | 1998 |
Frequency of recurrent lupus nephritis among ninety-seven renal transplant patients during the cyclosporine era.
Topics: Adult; Analysis of Variance; Antibodies; Antibodies, Antinuclear; Antiphospholipid Syndrome; Biopsy; Cadaver; Cell Count; Cell Size; Cyclosporine; Female; Follow-Up Studies; Glomerular Mesangium; Graft Rejection; Graft vs Host Disease; Histocompatibility Testing; Humans; Immunosuppressive Agents; Kidney Failure, Chronic; Kidney Glomerulus; Kidney Transplantation; Lupus Erythematosus, Systemic; Lupus Nephritis; Male; Middle Aged; Recurrence; Renal Dialysis; Time Factors; Transplantation Conditioning | 1998 |
Successful treatment with plasmapheresis, cyclophosphamide, and cyclosporin A in type B syndrome of insulin resistance. Case report.
Topics: Adipocytes; Animals; Autoantibodies; Combined Modality Therapy; Cyclophosphamide; Cyclosporine; Female; Humans; Hyperglycemia; Immunosuppressive Agents; Insulin; Insulin Resistance; Lupus Erythematosus, Systemic; Middle Aged; Plasmapheresis; Prednisolone; Rats; Receptor, Insulin | 1998 |
Outcome of renal transplantation in ninety-seven cyclosporine-era patients with systemic lupus erythematosus and matched controls.
Topics: Adult; Antirheumatic Agents; Cyclosporine; Female; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Kidney Failure, Chronic; Kidney Transplantation; Lupus Erythematosus, Systemic; Male; Multivariate Analysis; Probability; Proportional Hazards Models; Survival Analysis; Tacrolimus; Treatment Outcome | 1998 |
FK-506 (tacrolimus) therapy for an unusual SLE-like disease.
Topics: Adult; Anti-Bacterial Agents; Autoantibodies; Autoimmune Diseases; Cyclosporine; Female; Humans; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Tacrolimus | 1998 |
Cyclosporine in the treatment of autoimmune disorders: a 10-year experience.
Topics: Adult; Aged; Arthritis, Rheumatoid; Autoimmune Diseases; Behcet Syndrome; Central Nervous System Diseases; Cyclosporine; Female; Humans; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Male; Middle Aged; Retrospective Studies; Vasculitis | 1998 |
Effective treatment of autoimmune diseases with extremely low dose cyclosporine.
Topics: Adult; Autoimmune Diseases; Cyclosporine; Female; Humans; Immunosuppressive Agents; Lung Diseases, Interstitial; Lupus Erythematosus, Systemic; Male; Middle Aged; Sjogren's Syndrome; Thrombocytopenia | 1998 |
Successful pregnancy and delivery in a case of systemic lupus erythematosus treated with immunoadsorption therapy and cyclosporin A.
Topics: Adult; Anti-Inflammatory Agents; Antibodies, Antinuclear; Cyclosporine; Delivery, Obstetric; Exanthema; Female; Humans; Immunosorbent Techniques; Immunosuppressive Agents; Immunotherapy; Lupus Erythematosus, Systemic; Plasmapheresis; Prednisolone; Pregnancy; Pregnancy Complications; Treatment Outcome | 1999 |
Relationship between CD4+/CD8+ T cell ratio and T cell activation in systemic lupus erythematosus.
Topics: Adult; CD4-CD8 Ratio; Colonic Diseases; Cyclosporine; Female; HLA-DR Antigens; Humans; Interphase; Lupus Erythematosus, Systemic; Lymphocyte Activation; Male; Middle Aged; Prednisolone; Severity of Illness Index; T-Lymphocytes; Ulcer | 1999 |
Treatment of chronic bilateral pleural effusions with intravenous immunoglobulin and cyclosporin.
Topics: Antibodies, Antinuclear; Ascites; Complement C3; Complement C4; Cyclosporine; DNA; Female; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Middle Aged; Pleura; Pleural Effusion | 1999 |
[Nephrotic syndrome refractory to conventional therapy].
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Capillary Permeability; Cyclosporine; Drug Evaluation; Drug Therapy, Combination; Female; Glomerulonephritis, Membranous; Glomerulosclerosis, Focal Segmental; Humans; Immunosuppressive Agents; Kidney Glomerulus; Lupus Erythematosus, Systemic; Lymphokines; Male; Middle Aged; Nephrotic Syndrome; Proteinuria; Treatment Outcome | 1999 |
[Cyclosporin A reverses steroid-resistance induced by P-glycoprotein in patients with SLE].
Topics: Anti-Inflammatory Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cyclosporine; Drug Resistance, Multiple; Humans; Lupus Erythematosus, Systemic; Steroids | 1999 |
An audit of cyclosporin for systemic lupus erythematosus and related overlap syndromes: limitations of its use.
Topics: Adult; Cyclosporine; Drug Administration Schedule; Female; Humans; Hypertension; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Male; Retrospective Studies | 2000 |
Changes of CD4/CD8 ratio and interleukin-16 in systemic lupus erythematosus.
Topics: Adrenal Cortex Hormones; Adult; Antirheumatic Agents; CD4-CD8 Ratio; Cyclosporine; Data Interpretation, Statistical; Enzyme-Linked Immunosorbent Assay; Female; HLA-DR Antigens; Humans; Immunosuppressive Agents; Interleukin-16; Lupus Erythematosus, Systemic; Lymphocyte Activation; Male; Middle Aged; T-Lymphocytes | 2000 |
Successful treatment of pure red cell aplasia associated with systemic lupus erythematosus with cyclosporin A.
Topics: Adult; Antirheumatic Agents; Cyclosporine; Female; Humans; Lupus Erythematosus, Systemic; Red-Cell Aplasia, Pure | 2000 |
Cyclosporin A and therapeutic plasma exchange in the treatment of severe systemic lupus erythematosus.
Topics: Adrenal Cortex Hormones; Adult; Antibodies, Antinuclear; Antigen-Antibody Complex; Azathioprine; Chi-Square Distribution; Combined Modality Therapy; Cyclophosphamide; Cyclosporine; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Male; Middle Aged; Plasma Exchange; Prognosis; Prospective Studies; Safety; Statistics, Nonparametric; Treatment Outcome | 2000 |
Remitting asymmetrical pitting oedema in systemic lupus erythematosus: two cases studied with magnetic resonance imaging.
Topics: Adult; Ankle; Cyclosporine; Disease Progression; Drug Therapy, Combination; Edema; Female; Functional Laterality; Humans; Lupus Erythematosus, Systemic; Magnetic Resonance Imaging; Methotrexate; Prednisone; Remission, Spontaneous; Treatment Outcome; Wrist | 2000 |
Safety profile and causes of withdrawal due to adverse events in systemic lupus erythematosus patients treated long-term with cyclosporine A.
Topics: Adolescent; Adult; Child; Cyclosporine; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Male; Middle Aged; Retrospective Studies | 2000 |
A case of systemic lupus erythematosus complicated with multicentric reticulohistiocytosis (MRH): successful treatment of MRH and lupus nephritis with cyclosporin A.
Topics: Adult; Antirheumatic Agents; Cyclosporine; Female; Histiocytosis; Humans; Lupus Erythematosus, Systemic | 2001 |
[A case of systemic lupus erythematosus with hemophagocytic syndrome and cytophagic histiocytic panniculitis].
Topics: Adult; Cyclophosphamide; Cyclosporine; Histiocytosis, Non-Langerhans-Cell; Humans; Lupus Erythematosus, Systemic; Male; Methylprednisolone; Panniculitis; Pulse Therapy, Drug | 2001 |
[Blistering cutaneous lesions in a patient with systemic lupus erythematosis].
Topics: Adult; Cyclosporine; Diagnosis, Differential; Female; Humans; Immunosuppressive Agents; Lupus Erythematosus, Cutaneous; Lupus Erythematosus, Systemic; Stevens-Johnson Syndrome | 2001 |
Benefits of leflunomide in systemic lupus erythematosus: a pilot observational study.
Topics: Adult; Blood Sedimentation; Cyclosporine; Female; Humans; Isoxazoles; Leflunomide; Lupus Erythematosus, Systemic; Methotrexate; Pilot Projects; Retrospective Studies | 2001 |
Cyclosporin A in a pregnant patient affected with systemic lupus erythematosus.
Topics: Adult; Cyclosporine; Female; Humans; Lupus Erythematosus, Systemic; Pregnancy; Pregnancy Complications | 1992 |
The effect of cyclosporin A on early and late stages of experimental lupus.
Topics: Animals; Antibody Formation; Autoantibodies; Cyclosporine; Female; Kidney; Lupus Erythematosus, Systemic; Lymph Nodes; Mice; Mice, Inbred BALB C; T-Lymphocytes, Helper-Inducer | 1992 |
Fatal septicaemia due to Listeria monocytogenes in a patient with systemic lupus erythematosus receiving cyclosporin and high prednisone doses.
Topics: Adolescent; Bacteremia; Cyclosporine; Drug Therapy, Combination; Female; Humans; Listeriosis; Lupus Erythematosus, Systemic; Prednisone | 1992 |
Treatment of autoimmune patients.
Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Antinuclear; Antineoplastic Agents; Autoimmune Diseases; Chloroquine; Complement C3; Complement C4; Cyclosporine; Glutamine; Humans; Immunologic Tests; Lupus Erythematosus, Systemic; Parathyroid Hormone; Taurine; Thymus Hormones; Vitamin A | 1991 |
Soluble HLA-DR molecules in patients with HLA class II versus class I associated disorders.
Topics: Arthritis, Psoriatic; Arthritis, Rheumatoid; Autoimmune Diseases; beta 2-Microglobulin; Blood Sedimentation; Cyclosporine; HLA-DR Antigens; Humans; Interferon-gamma; Longitudinal Studies; Lupus Erythematosus, Systemic; Lyme Disease; Scleroderma, Localized; Spondylitis; Vasculitis | 1991 |
5-Methylcytosine content of DNA in blood, synovial mononuclear cells and synovial tissue from patients affected by autoimmune rheumatic diseases.
Topics: 5-Methylcytosine; Adult; Autoimmune Diseases; Chromatography, High Pressure Liquid; Cyclosporine; Cytosine; DNA; Female; Humans; Leukocytes, Mononuclear; Lupus Erythematosus, Systemic; Male; Methylation; Middle Aged; Rheumatic Diseases; Synovial Membrane | 1991 |
Cyclosporine A and cyclosporine G enhance IgG rheumatoid factor production in MRL/lpr mice.
Topics: Animals; Antibodies, Antinuclear; Cyclosporine; Cyclosporins; Immunoglobulin G; Leukocyte Count; Lupus Erythematosus, Systemic; Lymphoid Tissue; Lymphoproliferative Disorders; Mice; Mice, Inbred Strains; Mice, Mutant Strains; Organ Size; Rheumatoid Factor; Stimulation, Chemical | 1988 |
Ciclosporin treatment in experimental autoimmune myasthenia gravis.
Topics: Animals; Autoantibodies; Cyclosporine; Cyclosporins; Diabetes Mellitus, Type 1; Disease Models, Animal; Female; Lupus Erythematosus, Systemic; Mice; Mice, Inbred NZB; Myasthenia Gravis; Rats; Rats, Inbred BB; Rats, Inbred Lew | 1988 |
Successful treatment of autoimmunity in (NZB X NZW)F1 mice with cyclosporin and (Nva2)-cyclosporin: I. Reduction of autoantibodies.
Topics: Age Factors; Animals; Antibodies, Antinuclear; Autoantibodies; Autoimmune Diseases; Cyclosporine; Cyclosporins; DNA; Erythrocytes; Lupus Erythematosus, Systemic; Mice; Mice, Inbred NZB | 1986 |